Generian and Mitobridge Form Alliance to Develop Novel Small Molecules for Undruggable Targets
By Swati Sharan
Pharma Deals Review: Vol 2022 Issue 7 (Table of Contents)
Published: 18 Jul-2022
DOI: 10.3833/pdr.v2022.i7.2706 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Generian and Mitobridge, an Astellas company, have entered into a collaboration and license agreement to discover and develop small molecules for undruggable therapeutic targets...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS